High‐dose chemotherapy followed by autologous stem cell rescue in Wilms tumors: French report on toxicity and efficacy-Reference-Cited by-同舟云学术

High‐dose chemotherapy followed by autologous stem cell rescue in Wilms tumors: French report on toxicity and efficacy

Published:2021-11-22 Issue:3 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Delafoy Manon¹,Verschuur Arnauld²,Scheleirmacher Gudrun³,Tabone Marie‐Dominique⁴,Sudour‐Bonnange Hélène⁵^ORCID,Thébaud Estelle⁶,Freycon Claire⁷,Notz‐Carrère Anne⁸,Boulanger Cécile⁹,Pellier Isabelle¹⁰,Irtan Sabine¹¹,Muracciole Xavier¹²,Coulomb‐L'Hermine Aurore¹³,Dijoud Frédérique¹⁴,Morelle Magali¹⁵,Bergeron Christophe¹⁶,Pasqualini Claudia¹^ORCID

Affiliation:

1. Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus Université Paris‐Saclay Villejuif France

2. Pediatric Hematology‐Oncology Department La Timone Hospital, AP‐HM Marseille France

3. Pediatric Onco‐Hematology Department Curie Institute Paris France

4. Pediatric Onco‐Hematology Department Armand Trousseau Hospital, APHP Paris France

5. Pediatric and AYA Oncology Department Centre Oscar Lambret Lille France

6. Pediatric Onco‐Hematology Department University Hospital Center of Nantes Nantes France

7. Pediatric Hematology‐Oncology Department University Hospital Center of Grenoble Grenoble France

8. Pediatric Onco‐Hematology Department University Hospital Center of Bordeaux Bordeaux France

9. Pediatric Hematology‐Oncology Department University Hospital Center of Toulouse Toulouse France

10. Pediatric Hematology‐Oncology Department University Hospital Center of Angers Angers France

11. Department of Pediatric Surgery Sorbonne Université, Armand Trousseau Hospital, APHP Paris France

12. Department of Radiotherapy La Timone Hospital, AP‐HM Marseille France

13. Department of Pathology Armand Trousseau Hospital, APHP Paris France

14. Department of Pathology Hospices Civiles de Lyon Lyon France

15. Department of Statistic Centre Léon Bérard Lyon France

16. Pediatric Onco‐Hematology Department Centre Leon Bérard/IHOPE Lyon France

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29431

Reference22 articles.

1. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

2. Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

3. A phase III randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for high-risk neuroblastoma (HR-NB): A Children's Oncology Group (COG) study.

4. Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients

5. Tandem high-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuro-ectodermic tumors

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review;Cancers;2022-05-24